Targeting mitochondrial quality control: new therapeutic strategies for major diseases

作者全名："Hong, Wei-Long; Huang, He; Zeng, Xue; Duan, Chen-Yang"

作者地址："[Hong, Wei-Long; Huang, He; Zeng, Xue; Duan, Chen-Yang] Chongqing Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Chongqing 400010, Peoples R China"

通信作者："Duan, CY (通讯作者)，Chongqing Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Chongqing 400010, Peoples R China."

来源：MILITARY MEDICAL RESEARCH

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001295033700002

JCR分区：Q1

影响因子：21.1

年份：2024

卷号：11

期号：1

开始页：　

结束页：　

文献类型：Review

关键词：Major diseases; Mitochondrial quality control; Mitochondrial targeted therapy

摘要："Mitochondria play a crucial role in maintaining the normal physiological state of cells. Hence, ensuring mitochondrial quality control is imperative for the prevention and treatment of numerous diseases. Previous reviews on this topic have however been inconsistencies and lack of systematic organization. Therefore, this review aims to provide a comprehensive and systematic overview of mitochondrial quality control and explore the possibility of targeting the same for the treatment of major diseases. This review systematically summarizes three fundamental characteristics of mitochondrial quality control, including mitochondrial morphology and dynamics, function and metabolism, and protein expression and regulation. It also extensively examines how imbalances in mitochondrial quality are linked to major diseases, such as ischemia-hypoxia, inflammatory disorders, viral infections, metabolic dysregulations, degenerative conditions, and tumors. Additionally, the review explores innovative approaches to target mitochondrial quality control, including using small molecule drugs that regulate critical steps in maintaining mitochondrial quality, nanomolecular materials designed for precise targeting of mitochondria, and novel cellular therapies, such as vesicle therapy and mitochondrial transplantation. This review offers a novel perspective on comprehending the shared mechanisms underlying the occurrence and progression of major diseases and provides theoretical support and practical guidance for the clinical implementation of innovative therapeutic strategies that target mitochondrial quality control for treating major diseases."

基金机构：National Natural Science Foundation of China

基金资助正文：Not applicable.